middle.news
Atomo Diagnostics Boosts FY26 Revenue 40% with Expanding HIV and OEM Sales
9:46am on Thursday 23rd of July, 2026 AEST
•
Healthcare
Read Story
Atomo Diagnostics Boosts FY26 Revenue 40% with Expanding HIV and OEM Sales
9:46am on Thursday 23rd of July, 2026 AEST
Key Points
FY26 revenue rises 40% to $5.3 million
HIV self-test sales and OEM orders fuel growth
Pharmacy network expands in Australia and New Zealand
Syphilis test clinical trials set for mid FY27
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Atomo Diagnostics (ASX:AT1)
OPEN ARTICLE